Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 5/10

vs
industry
vs
history
Cash to Debt 0.48
OMI's Cash to Debt is ranked lower than
53% of the 51 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.66 vs. OMI: 0.48 )
OMI' s 10-Year Cash to Debt Range
Min: 0   Max: 0.76
Current: 0.48

0
0.76
Equity to Asset 0.44
OMI's Equity to Asset is ranked higher than
65% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.42 vs. OMI: 0.44 )
OMI' s 10-Year Equity to Asset Range
Min: 0.21   Max: 0.47
Current: 0.44

0.21
0.47
F-Score: 6
Z-Score: 5.96
M-Score: -2.63
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating margin (%) 2.18
OMI's Operating margin (%) is ranked higher than
52% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.29 vs. OMI: 2.18 )
OMI' s 10-Year Operating margin (%) Range
Min: 0.89   Max: 2.57
Current: 2.18

0.89
2.57
Net-margin (%) 1.22
OMI's Net-margin (%) is ranked higher than
50% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.88 vs. OMI: 1.22 )
OMI' s 10-Year Net-margin (%) Range
Min: -0.38   Max: 1.36
Current: 1.22

-0.38
1.36
ROE (%) 10.83
OMI's ROE (%) is ranked higher than
68% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 9.25 vs. OMI: 10.83 )
OMI' s 10-Year ROE (%) Range
Min: -4.8   Max: 17.41
Current: 10.83

-4.8
17.41
ROA (%) 4.77
OMI's ROA (%) is ranked higher than
74% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.83 vs. OMI: 4.77 )
OMI' s 10-Year ROA (%) Range
Min: -1.32   Max: 6.07
Current: 4.77

-1.32
6.07
ROC (Joel Greenblatt) (%) 23.96
OMI's ROC (Joel Greenblatt) (%) is ranked higher than
64% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 26.42 vs. OMI: 23.96 )
OMI' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 7.07   Max: 33.41
Current: 23.96

7.07
33.41
Revenue Growth (%) 3.70
OMI's Revenue Growth (%) is ranked higher than
54% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 8.80 vs. OMI: 3.70 )
OMI' s 10-Year Revenue Growth (%) Range
Min: -0.6   Max: 13.5
Current: 3.7

-0.6
13.5
EBITDA Growth (%) 3.30
OMI's EBITDA Growth (%) is ranked higher than
56% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 11.10 vs. OMI: 3.30 )
OMI' s 10-Year EBITDA Growth (%) Range
Min: -1.8   Max: 37.2
Current: 3.3

-1.8
37.2
EPS Growth (%) 0.40
OMI's EPS Growth (%) is ranked higher than
56% of the 34 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.40 vs. OMI: 0.40 )
OMI' s 10-Year EPS Growth (%) Range
Min: -5.6   Max: 58.7
Current: 0.4

-5.6
58.7
» OMI's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2013

OMI Guru Trades in Q1 2013

Joel Greenblatt 58,424 sh (New)
John Keeley 18,945 sh (+33.93%)
Chuck Royce 1,830,550 sh (+8.93%)
Pioneer Investments 577,980 sh (+0.22%)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Mario Gabelli 141,250 sh (unchged)
John Hussman 2,000 sh (unchged)
Paul Tudor Jones Sold Out
David Dreman 1,090,985 sh (-1.13%)
» More
Q2 2013

OMI Guru Trades in Q2 2013

Paul Tudor Jones 9,500 sh (New)
Joel Greenblatt 198,213 sh (+239.27%)
John Hussman 3,500 sh (+75%)
Mario Gabelli 205,829 sh (+45.72%)
John Keeley 27,345 sh (+44.34%)
Pioneer Investments 583,777 sh (+1%)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Chuck Royce 1,830,550 sh (unchged)
David Dreman 857,826 sh (-21.37%)
» More
Q3 2013

OMI Guru Trades in Q3 2013

John Keeley 30,845 sh (+12.8%)
Joel Greenblatt 220,554 sh (+11.27%)
Paul Tudor Jones 10,100 sh (+6.32%)
Pioneer Investments 583,839 sh (+0.01%)
Chuck Royce 1,830,550 sh (unchged)
Vanguard Health Care Fund 3,000,000 sh (unchged)
John Hussman Sold Out
Mario Gabelli 205,229 sh (-0.29%)
David Dreman 230,613 sh (-73.12%)
» More
Q4 2013

OMI Guru Trades in Q4 2013

Jim Simons 70,550 sh (New)
Steven Cohen 15,553 sh (New)
Paul Tudor Jones 17,380 sh (+72.08%)
Joel Greenblatt 373,228 sh (+69.22%)
David Dreman 253,937 sh (+10.11%)
John Keeley 32,845 sh (+6.48%)
Pioneer Investments 583,839 sh (unchged)
Vanguard Health Care Fund 3,000,000 sh (unchged)
Mario Gabelli 205,229 sh (unchged)
Chuck Royce 1,830,550 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with OMI

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2013-12-31 Add 69.22%0.13%$33.95 - $38.23 $ 34.51-6%373228
David Dreman 2013-09-30 Reduce -73.12%0.63%$33.5 - $36.26 $ 34.51-1%230613
John Hussman 2013-09-30 Sold Out 0.01%$33.5 - $36.26 $ 34.51-1%0
Joel Greenblatt 2013-06-30 Add 239.27%0.2%$30.12 - $35.43 $ 34.514%198213
David Dreman 2013-06-30 Reduce -21.37%0.2%$30.12 - $35.43 $ 34.514%857826
John Keeley 2013-06-30 Add 44.34%0.01%$30.12 - $35.43 $ 34.514%27345
Mario Gabelli 2013-06-30 Add 45.72%0.01%$30.12 - $35.43 $ 34.514%205829
John Hussman 2013-06-30 Add 75%$30.12 - $35.43 $ 34.514%3500
Joel Greenblatt 2013-03-31 New Buy0.1%$28.51 - $32.56 $ 34.5112%58424
John Keeley 2013-03-31 Add 33.93%$28.51 - $32.56 $ 34.5112%18945
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 19.60
OMI's P/E(ttm) is ranked higher than
70% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 23.10 vs. OMI: 19.60 )
OMI' s 10-Year P/E(ttm) Range
Min: 13.55   Max: 35.15
Current: 19.6

13.55
35.15
P/B 2.13
OMI's P/B is ranked higher than
62% of the 50 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.13 vs. OMI: 2.13 )
OMI' s 10-Year P/B Range
Min: 1.79   Max: 3.1
Current: 2.13

1.79
3.1
P/S 0.24
OMI's P/S is ranked higher than
82% of the 49 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.50 vs. OMI: 0.24 )
OMI' s 10-Year P/S Range
Min: 0.18   Max: 0.29
Current: 0.24

0.18
0.29
PFCF 26.96
OMI's PFCF is ranked higher than
56% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 18.08 vs. OMI: 26.96 )
OMI' s 10-Year PFCF Range
Min: 5.38   Max: 2216.7
Current: 26.96

5.38
2216.7
EV-to-EBIT 11.56
OMI's EV-to-EBIT is ranked higher than
77% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 17.09 vs. OMI: 11.56 )
OMI' s 10-Year EV-to-EBIT Range
Min: 8   Max: 20.3
Current: 11.56

8
20.3
PEG 9.24
OMI's PEG is ranked higher than
50% of the 30 Companies
in the Global Medical Distribution industry.

( Industry Median: 2.49 vs. OMI: 9.24 )
OMI' s 10-Year PEG Range
Min: 0.89   Max: 9.88
Current: 9.24

0.89
9.88
Shiller P/E 19.30
OMI's Shiller P/E is ranked higher than
90% of the 31 Companies
in the Global Medical Distribution industry.

( Industry Median: 31.71 vs. OMI: 19.30 )
OMI' s 10-Year Shiller P/E Range
Min: 16.31   Max: 29.65
Current: 19.3

16.31
29.65

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 2.80
OMI's Dividend Yield is ranked higher than
79% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.57 vs. OMI: 2.80 )
OMI' s 10-Year Dividend Yield Range
Min: 1.31   Max: 3.19
Current: 2.8

1.31
3.19
Dividend Payout 0.51
OMI's Dividend Payout is ranked lower than
56% of the 36 Companies
in the Global Medical Distribution industry.

( Industry Median: 0.30 vs. OMI: 0.51 )
OMI' s 10-Year Dividend Payout Range
Min: 0.24   Max: 1.06
Current: 0.51

0.24
1.06
Dividend growth (3y) 10.70
OMI's Dividend growth (3y) is ranked higher than
68% of the 19 Companies
in the Global Medical Distribution industry.

( Industry Median: 10.70 vs. OMI: 10.70 )
OMI' s 10-Year Dividend growth (3y) Range
Min: 3.5   Max: 19.7
Current: 10.7

3.5
19.7
Yield on cost (5-Year) 4.89
OMI's Yield on cost (5-Year) is ranked higher than
84% of the 43 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.86 vs. OMI: 4.89 )
OMI' s 10-Year Yield on cost (5-Year) Range
Min: 2.29   Max: 5.57
Current: 4.89

2.29
5.57
Share Buyback Rate -0.10
OMI's Share Buyback Rate is ranked higher than
73% of the 33 Companies
in the Global Medical Distribution industry.

( Industry Median: -0.30 vs. OMI: -0.10 )
OMI' s 10-Year Share Buyback Rate Range
Min: -0.1   Max: -5.3
Current: -0.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 3.08
OMI's Price/Tangible Book is ranked higher than
53% of the 38 Companies
in the Global Medical Distribution industry.

( Industry Median: 3.08 vs. OMI: 3.08 )
OMI' s 10-Year Price/Tangible Book Range
Min: 2.72   Max: 175
Current: 3.08

2.72
175
Price/DCF (Projected) 1.25
OMI's Price/DCF (Projected) is ranked higher than
75% of the 32 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.25 vs. OMI: 1.25 )
OMI' s 10-Year Price/DCF (Projected) Range
Min: 0.93   Max: 2.72
Current: 1.25

0.93
2.72
Price/Median PS Value 1.04
OMI's Price/Median PS Value is ranked higher than
72% of the 47 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.22 vs. OMI: 1.04 )
OMI' s 10-Year Price/Median PS Value Range
Min: 0.41   Max: 1.1
Current: 1.04

0.41
1.1
Price/Graham Number 1.64
OMI's Price/Graham Number is ranked higher than
59% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 1.70 vs. OMI: 1.64 )
OMI' s 10-Year Price/Graham Number Range
Min: 1.36   Max: 14.38
Current: 1.64

1.36
14.38
Earnings Yield (Greenblatt) 8.70
OMI's Earnings Yield (Greenblatt) is ranked higher than
79% of the 48 Companies
in the Global Medical Distribution industry.

( Industry Median: 5.90 vs. OMI: 8.70 )
OMI' s 10-Year Earnings Yield (Greenblatt) Range
Min: 4.9   Max: 12.4
Current: 8.7

4.9
12.4
Forward Rate of Return (Yacktman) 6.89
OMI's Forward Rate of Return (Yacktman) is ranked higher than
59% of the 37 Companies
in the Global Medical Distribution industry.

( Industry Median: 14.26 vs. OMI: 6.89 )
OMI' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 4.1   Max: 19.9
Current: 6.89

4.1
19.9

Business Description

Industry: Medical Distribution » Medical Distribution
Compare:ABC, MCK, CAH, SHTDF, HSIC » details
Traded in other countries:6OM.Germany
Owens & Minor, Inc. was founded in 1882 and incorporated in 1926 in Richmond, Virginia. The Company is engaged in providing distribution, third-party logistics, and other supply-chain management services to healthcare providers and suppliers of medical and surgical products, and is a national distributor of medical and surgical supplies to the acute-care market. Its core service consists of the distribution of finished medical and surgical products, procured from nearly 1,300 suppliers, to approximately 3, 600 healthcare providers from 48 distribution and service centers nationwide. In certain cases, it also performs distribution and supply-chain management services on an outsourced basis from facilities that are owned by customers. In serving its healthcare customers, including acute-care and alternate-site providers and healthcare products suppliers, the Company also provides a range of data analysis tools and outsourced resource management and consulting services, such as inventory, supply spending and contract management, as well as low-unit-of measure shipments and tailored deliveries. In the European market, the company provides third-party logistics services for the manufacturers and suppliers of healthcare and life-science products. It typically provides supply-chain management services, including distribution services, under contractual arrangements with healthcare providers such as hospitals, hospital-based systems, and alternate-site providers. The Company offers customers a broad portfolio of products and services. Distribution of medical and surgical supplies to healthcare providers, include MediChoice private label product line. The Company currently provides distribution, outsourced resource management and/or consulting services to approximately 4,000 healthcare providers, primarily hospitals in the acute-care market. Its sales and marketing organization is built to support a customer base with sales and service teams positioned within the markets it serves so that it can effectively respond to local needs. The Company competes with a smaller national distributor of medical and surgical supplies, Medline, Inc., and a number of regional and local distributors. The medical/surgical supply distribution industry is subject to regulation by federal, state and local government agencies.

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide